Back
Rigel Pharmaceuticals Quote, Financials, Valuation and Earnings
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
54
RIGL
Rigel Pharmaceuticals
Last Price:
14.80
Seasonality Move:
14.12%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeRigel Pharmaceuticals Price Quote
$14.80
+0.30 (+2.07%)
(Updated: November 6, 2024 at 10:30 AM ET)
Rigel Pharmaceuticals Key Stats
Buy
54
Rigel Pharmaceuticals (RIGL)
is a Buy
Day range:
$13.91 - $14.57
52-week range:
$7.48 - $17.30
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.95
P/B ratio:
0%
Volume:
116.7K
Avg. volume:
168.1K
1-year change:
64.57%
Market cap:
$255.1M
Revenue:
$116.9M
EPS:
$-0.76
How Much Does Rigel Pharmaceuticals Make?
-
How Much Are Rigel Pharmaceuticals's Sales Annually?
RIGL Revenues are $116.9M -
How Much Profit Does Rigel Pharmaceuticals's Make A Year?
RIGL net income is -$25.1M
Is Rigel Pharmaceuticals Growing As A Company?
-
What Is Rigel Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.37% -
What Is Rigel Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Rigel Pharmaceuticals Stock Price Performance
-
Did Rigel Pharmaceuticals Stock Go Up Last Month?
Rigel Pharmaceuticals share price went down by -9.6% last month -
Did RIGL's Share Price Rise Over The Last Year?
RIGL share price rose by 64.57% over the past 1 year
What Is Rigel Pharmaceuticals 52-Week High & Low?
-
What Is Rigel Pharmaceuticals’s 52-Week High Share Price?
Rigel Pharmaceuticals has traded as high as $17.30 over the past 52 weeks -
What Is Rigel Pharmaceuticals’s 52-Week Low Share Price?
Rigel Pharmaceuticals has traded as low as $7.48 over the past 52 weeks
Rigel Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Rigel Pharmaceuticals?
-
How Much Debt Does Rigel Pharmaceuticals Have?
Total long term debt quarterly is $59.7M -
How Much Cash Does Rigel Pharmaceuticals Have?
Cash and short term investments quarterly total is $49.1M -
What Is Rigel Pharmaceuticals’s Book Value Per Share?
Book value per share is -1.70
Is Rigel Pharmaceuticals Cash Flow Positive?
-
What Is RIGL Cash Flow From Operations?
Cash flow from operations (TTM) is -$12.3M -
What Is Rigel Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$3.6M -
What Is Rigel Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $3.2M
Rigel Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
RIGL return on invested capital is -48.07% -
What Is Rigel Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -11.77% -
What Is RIGL Return On Equity?
ROE is a measure of profitability and is 0%
Rigel Pharmaceuticals Earnings Date & Stock Price
-
What Is Rigel Pharmaceuticals's Stock Price Today?
A single share of RIGL can be purchased today for 14.50 -
What Is Rigel Pharmaceuticals’s Stock Symbol?
Rigel Pharmaceuticals trades on the nasdaq under the ticker symbol: RIGL -
When Is Rigel Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Rigel Pharmaceuticals is scheduled on November 7, 2024 -
When Is RIGL's next ex-dividend date?
Rigel Pharmaceuticals's next ex-dividend date is November 6, 2024 -
How To Buy Rigel Pharmaceuticals Stock?
You can buy Rigel Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Rigel Pharmaceuticals Competitors
-
Who Are Rigel Pharmaceuticals's Competitors?
Below is a list of companies who compete with Rigel Pharmaceuticals or are related in some way:
Rigel Pharmaceuticals Dividend Yield
-
What Is RIGL Dividend Yield?
Rigel Pharmaceuticals’s dividend yield currently is 0% -
What Is Rigel Pharmaceuticals’s Payout Ratio?
Rigel Pharmaceuticals’s payout ratio is 0% -
When Did Rigel Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 6, 2024 -
What Is Rigel Pharmaceuticals’s Dividend Per Share?
Rigel Pharmaceuticals pays a dividend of $0.00 per share
Rigel Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 66.22% |
| Revenue: | 37.03% | 9.31% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 4 |
| Sell Recommendations: | 0 |
| Price Target: | 26.75 |
| Upside from Last Price: | 84.48% |